TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: COMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes
Brief Summary: The study will implement and evaluate, using a pragmatic comparative effectiveness trial, a unique collaborative, stepped-care intervention for patients with uncontrolled Type 2 diabetes and co-morbid distress and/or depression.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Toolkit | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: Toolkit; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
B: Arm Label: Integrated Behavioral Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Behavioral Care | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Integrated Behavioral Care; Assigned to Arm(s): Integrated Behavioral Intervention
C: Arm Label: Training course for practice nurses in autonomy support; Type: EXPERIMENTAL; Interventions: Behavioral: Training course for practice nurses in autonomy support | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training course for practice nurses in autonomy support; Assigned to Arm(s): Training course for practice nurses in autonomy support
D: Intervention Type: BEHAVIORAL; Name: Telephonic diabetes care; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hospitalization at Home Pilot: The Acute Care Home Hospital Program for Adults
Brief Summary: The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity counseling program | Arm Label: 2; Type: SHAM_COMPARATOR; Interventions: Behavioral: sham counseling program | Intervention Type: BEHAVIORAL; Name: physical activity counseling program; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: sham counseling program; Assigned to Arm(s): 2
B: Arm Label: Exercise intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise intervention
C: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Yamax Digi-Walker CW-700 | Intervention Type: DEVICE; Name: Yamax Digi-Walker CW-700; Assigned to Arm(s): Intervention
D: Arm Label: Inpatient hospitalization; Type: ACTIVE_COMPARATOR; Interventions: Other: Inpatient Hospitalization | Arm Label: Home hospitalization; Type: EXPERIMENTAL; Interventions: Other: Home hospitalization | Intervention Type: OTHER; Name: Home hospitalization; Assigned to Arm(s): Home hospitalization | Intervention Type: OTHER; Name: Inpatient Hospitalization; Assigned to Arm(s): Inpatient hospitalization

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hospitalization at Home Pilot: The Acute Care Home Hospital Program for Adults
Brief Summary: The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.


Options:
A: Arm Label: Inpatient hospitalization; Type: ACTIVE_COMPARATOR; Interventions: Other: Inpatient Hospitalization | Arm Label: Home hospitalization; Type: EXPERIMENTAL; Interventions: Other: Home hospitalization | Intervention Type: OTHER; Name: Home hospitalization; Assigned to Arm(s): Home hospitalization | Intervention Type: OTHER; Name: Inpatient Hospitalization; Assigned to Arm(s): Inpatient hospitalization
B: Arm Label: TCM integrated group; Type: ACTIVE_COMPARATOR; Interventions: Other: acupuncture, massage and basic TCM treatment | Arm Label: Western Medicine group; Type: ACTIVE_COMPARATOR; Interventions: Other: rehabilitation and WM basic treatment | Intervention Type: OTHER; Name: acupuncture, massage and basic TCM treatment; Assigned to Arm(s): TCM integrated group | Intervention Type: OTHER; Name: rehabilitation and WM basic treatment; Assigned to Arm(s): Western Medicine group
C: Intervention Type: PROCEDURE; Name: structured therapeutic chain of stroke treatment; Assigned to Arm(s): N/A
D: Arm Label: Inpatient hospitalization; Type: ACTIVE_COMPARATOR; Interventions: Other: Traditional inpatient hospitalization | Arm Label: Home hospitalization; Type: EXPERIMENTAL; Interventions: Other: Home hospitalization | Intervention Type: OTHER; Name: Home hospitalization; Assigned to Arm(s): Home hospitalization | Intervention Type: OTHER; Name: Traditional inpatient hospitalization; Assigned to Arm(s): Inpatient hospitalization

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Topical Tranexamic Acid and Floseal® on Blood Loss After Total Knee Arthroplasty in Patients With a Thromboembolic Risk
Brief Summary: Our purpose of this study is to conduct a prospective randomized controlled trial to investigate the blood-conservation effect of this two topical hemostatic agents in primary TKA procedures in patients with a risk of thromboembolic events. We will also observe if there is increased risk of thromboembolism by use of topical hemostatic agents.


Options:
A: Arm Label: Topical tranexamic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Topical tranexamic acid, Drug: Enoxaparin | Arm Label: Floseal®; Type: ACTIVE_COMPARATOR; Interventions: Drug: Floseal®, Drug: Enoxaparin | Arm Label: Control group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Enoxaparin | Intervention Type: DRUG; Name: Topical tranexamic acid; Assigned to Arm(s): Topical tranexamic acid | Intervention Type: DRUG; Name: Floseal®; Assigned to Arm(s): Floseal® | Intervention Type: DRUG; Name: Enoxaparin; Assigned to Arm(s): Control group, Floseal®, Topical tranexamic acid
B: Arm Label: Evicel; Type: EXPERIMENTAL; Interventions: Drug: Evicel | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Evicel; Assigned to Arm(s): Evicel
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic acid | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sodium Chloride 0.9% | Intervention Type: DRUG; Name: Tranexamic acid; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Sodium Chloride 0.9%; Assigned to Arm(s): 2
D: Arm Label: Peri-articular group; Type: EXPERIMENTAL; Interventions: Drug: Peri-articular tranexamic acid | Arm Label: Intravenous group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intravenous tranexamic acid | Intervention Type: DRUG; Name: Peri-articular tranexamic acid; Assigned to Arm(s): Peri-articular group | Intervention Type: DRUG; Name: Intravenous tranexamic acid; Assigned to Arm(s): Intravenous group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (INNO2VATE - CORRECTION/CONVERSION)
Brief Summary: A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction or maintenance treatment of anemia in participants with incident dialysis-dependent chronic kidney disease (DD-CKD).


Options:
A: Arm Label: Molidustat (BAY 85-3934)(25mg); Type: EXPERIMENTAL; Interventions: Drug: Molidustat (BAY 85-3934) | Arm Label: Molidustat (BAY 85-3934)(50mg); Type: EXPERIMENTAL; Interventions: Drug: Molidustat (BAY 85-3934) | Arm Label: Molidustat (BAY 85-3934) (75mg); Type: EXPERIMENTAL; Interventions: Drug: Molidustat (BAY 85-3934) | Arm Label: Molidustat (BAY 85-3934) (150mg); Type: EXPERIMENTAL; Interventions: Drug: Molidustat (BAY 85-3934) | Arm Label: Epoetin alfa/beta; Type: ACTIVE_COMPARATOR; Interventions: Biological: Epoetin alfa/beta | Intervention Type: DRUG; Name: Molidustat (BAY 85-3934); Assigned to Arm(s): Molidustat (BAY 85-3934) (150mg), Molidustat (BAY 85-3934) (75mg), Molidustat (BAY 85-3934)(25mg), Molidustat (BAY 85-3934)(50mg) | Intervention Type: BIOLOGICAL; Name: Epoetin alfa/beta; Assigned to Arm(s): Epoetin alfa/beta
B: Arm Label: Vadadustat; Type: EXPERIMENTAL; Interventions: Drug: Vadadustat | Arm Label: Darbepoetin alfa; Type: ACTIVE_COMPARATOR; Interventions: Drug: Darbepoetin alfa | Intervention Type: DRUG; Name: Vadadustat; Assigned to Arm(s): Vadadustat | Intervention Type: DRUG; Name: Darbepoetin alfa; Assigned to Arm(s): Darbepoetin alfa
C: Arm Label: Vadadustat; Type: EXPERIMENTAL; Interventions: Drug: Vadadustat | Arm Label: Darbepoetin alfa; Type: ACTIVE_COMPARATOR; Interventions: Drug: Darbepoetin alfa | Intervention Type: DRUG; Name: Vadadustat; Assigned to Arm(s): Vadadustat | Intervention Type: DRUG; Name: Darbepoetin alfa; Assigned to Arm(s): Darbepoetin alfa
D: Arm Label: Darbepoetin Alfa Injection; Type: EXPERIMENTAL; Interventions: Drug: Darbepoetin Alfa | Arm Label: Desidustat oral tablet; Type: ACTIVE_COMPARATOR; Interventions: Drug: Desidustat Oral Tablet | Intervention Type: DRUG; Name: Desidustat Oral Tablet; Assigned to Arm(s): Desidustat oral tablet | Intervention Type: DRUG; Name: Darbepoetin Alfa; Assigned to Arm(s): Darbepoetin Alfa Injection

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Corneal Accelerated Crosslinking Versus Conventional Treatment for Infectious Keratitis
Brief Summary: The objective of this study is to evaluate the efficacy and safety of accelerated cross-linking (Avedro Inc., Waltham, USA) in the management of microbial keratitis as adjunctive therapy.


Options:
A: Arm Label: conventional treatment; Type: EXPERIMENTAL; Interventions: Drug: topical voriconazole / levofloxacin systemic itraconazole | Arm Label: conventional treatment +CXL; Type: ACTIVE_COMPARATOR; Interventions: Drug: topical voriconazole / levofloxacin systemic itraconazole, Radiation: CXL | Intervention Type: DRUG; Name: topical voriconazole / levofloxacin systemic itraconazole; Assigned to Arm(s): conventional treatment, conventional treatment +CXL | Intervention Type: RADIATION; Name: CXL; Assigned to Arm(s): conventional treatment +CXL
B: Arm Label: Accelerated Corneal Cross-linking; Type: EXPERIMENTAL; Interventions: Procedure: Accelerated Corneal Cross-linking | Arm Label: Sham Accelerated Corneal Cross-linking; Type: SHAM_COMPARATOR; Interventions: Procedure: Accelerated Corneal Cross-linking | Intervention Type: PROCEDURE; Name: Accelerated Corneal Cross-linking; Assigned to Arm(s): Accelerated Corneal Cross-linking, Sham Accelerated Corneal Cross-linking
C: Arm Label: Bacterial ulcer cross-linking; Type: EXPERIMENTAL; Interventions: Procedure: Corneal Cross-linking | Arm Label: Bacterial ulcer control; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Corneal Cross-linking | Arm Label: Fungal ulcer cross-linking plus natamycin; Type: EXPERIMENTAL; Interventions: Procedure: Corneal Cross-linking, Drug: Anti Fungal Drug | Arm Label: Fungal ulcer control with natamycin; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Corneal Cross-linking, Drug: Anti Fungal Drug | Arm Label: Fungal ulcer cross-linking plus amphotericin; Type: EXPERIMENTAL; Interventions: Procedure: Corneal Cross-linking, Drug: Anti Fungal Drug | Arm Label: Fungal ulcer control with amphotericin; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Corneal Cross-linking, Drug: Anti Fungal Drug | Intervention Type: PROCEDURE; Name: Corneal Cross-linking; Assigned to Arm(s): Bacterial ulcer control, Bacterial ulcer cross-linking, Fungal ulcer control with amphotericin, Fungal ulcer control with natamycin, Fungal ulcer cross-linking plus amphotericin, Fungal ulcer cross-linking plus natamycin | Intervention Type: DRUG; Name: Anti Fungal Drug; Assigned to Arm(s): Fungal ulcer control with amphotericin, Fungal ulcer control with natamycin, Fungal ulcer cross-linking plus amphotericin, Fungal ulcer cross-linking plus natamycin
D: Arm Label: Riboflavin drops every minute; Type: ACTIVE_COMPARATOR; Interventions: Drug: Riboflavin | Arm Label: Riboflavin drops every 2 minutes; Type: ACTIVE_COMPARATOR; Interventions: Drug: Riboflavin | Intervention Type: DRUG; Name: Riboflavin; Assigned to Arm(s): Riboflavin drops every 2 minutes | Intervention Type: DRUG; Name: Riboflavin; Assigned to Arm(s): Riboflavin drops every minute

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Use of Iball Mobile Health Technology in Pelvic Floor Muscle Training in the Postpartum Period: a Pilot Mixed Methods Study
Brief Summary: he postpartum period is vulnerable to dysfunction of the pelvic floor musculature, which is associated with incontinence, pain, reduced stability of the core and functional deficits. The Society of Obstetricians and Gynaecologists of Canada recommends instruction on the correct performance of pelvic floor muscle exercises, commonly known as Kegels, as standard care. However, only a small proportion of women seek medical care for incontinence in Canada. Recently, there has been an influx of mobile Health technology applications marketed for pelvic floor restoration and fitness that have not been studied. The existence of mHealth technologies may represent an innovative mode to support pelvic health, however systematic exploration to substantiate claims and proposed benefit is required. This pilot study aims to understand the utility of a new mobile health application, iball, as a rehabilitation tool to promote optimal pelvic floor function and to correct pregnancy related pelvic floor dysfunction. The iball is comprised of a device and a mobile app, and it has been brought to market in Europe as a consumer product. The study aims to assess the acceptability, feasibility, and effectiveness of the iball as a pelvic floor muscle training intervention, in comparison to standard care.


Options:
A: Arm Label: Exercice; Type: OTHER; Interventions: Behavioral: preparation of the delivery | Arm Label: non-exercice; Type: OTHER; Interventions: Behavioral: preparation of the delivery | Intervention Type: BEHAVIORAL; Name: preparation of the delivery; Assigned to Arm(s): Exercice, non-exercice
B: Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Exercise / Physical Activity | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physical Exercise / Physical Activity; Assigned to Arm(s): Lifestyle intervention
C: Arm Label: Postpartum pelvic floor muscle training; Type: EXPERIMENTAL; Interventions: Other: Postpartum pelvic floor muscle training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Postpartum pelvic floor muscle training; Assigned to Arm(s): Postpartum pelvic floor muscle training
D: Arm Label: iball intervention; Type: EXPERIMENTAL; Interventions: Device: iball (mhealth application) | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: iball (mhealth application); Assigned to Arm(s): iball intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Use of Iball Mobile Health Technology in Pelvic Floor Muscle Training in the Postpartum Period: a Pilot Mixed Methods Study
Brief Summary: he postpartum period is vulnerable to dysfunction of the pelvic floor musculature, which is associated with incontinence, pain, reduced stability of the core and functional deficits. The Society of Obstetricians and Gynaecologists of Canada recommends instruction on the correct performance of pelvic floor muscle exercises, commonly known as Kegels, as standard care. However, only a small proportion of women seek medical care for incontinence in Canada. Recently, there has been an influx of mobile Health technology applications marketed for pelvic floor restoration and fitness that have not been studied. The existence of mHealth technologies may represent an innovative mode to support pelvic health, however systematic exploration to substantiate claims and proposed benefit is required. This pilot study aims to understand the utility of a new mobile health application, iball, as a rehabilitation tool to promote optimal pelvic floor function and to correct pregnancy related pelvic floor dysfunction. The iball is comprised of a device and a mobile app, and it has been brought to market in Europe as a consumer product. The study aims to assess the acceptability, feasibility, and effectiveness of the iball as a pelvic floor muscle training intervention, in comparison to standard care.


Options:
A: Arm Label: iball intervention; Type: EXPERIMENTAL; Interventions: Device: iball (mhealth application) | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: iball (mhealth application); Assigned to Arm(s): iball intervention
B: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise Group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Group | Intervention Type: BEHAVIORAL; Name: Exercise Group; Assigned to Arm(s): Exercise Group
C: Intervention Type: BEHAVIORAL; Name: Supervised exercise for the prevention high weight gain; Assigned to Arm(s): N/A
D: Arm Label: Study group - Treatment with PFFM; Type: EXPERIMENTAL; Interventions: Procedure: Pelvic floor fascial mobilization | Arm Label: Control group -; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Pelvic floor fascial mobilization; Assigned to Arm(s): Study group - Treatment with PFFM

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Phase II Study Of Nintedanib (BIBF1120) Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium
Brief Summary: The trial will recruit up to 120 patients; 90 with ovarian clear cell carcinoma and up to 30 with endometrial clear cell carcinoma. Patients will be randomised between chemotherapy and Nintedanib 200mg twice daily oral administration (PO) continuously. The primary diagnosis must be histologically confirmed and central pathological review of the presenting tumour or biopsy of relapsed disease must find at least 50% clear cell carcinoma with no serous differentiation


Options:
A: Arm Label: Nintedanib; Type: EXPERIMENTAL; Interventions: Drug: Nintedanib | Arm Label: Chemotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Paclitaxel, Drug: Pegylated Liposomal Doxorubicin (PLD), Drug: Topotecan, Drug: Carboplatin, Drug: Doxorubicin | Intervention Type: DRUG; Name: Nintedanib; Assigned to Arm(s): Nintedanib | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Chemotherapy | Intervention Type: DRUG; Name: Pegylated Liposomal Doxorubicin (PLD); Assigned to Arm(s): Chemotherapy | Intervention Type: DRUG; Name: Topotecan; Assigned to Arm(s): Chemotherapy | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): Chemotherapy | Intervention Type: DRUG; Name: Doxorubicin; Assigned to Arm(s): Chemotherapy
B: Arm Label: Arm I (closed to accrual 10/10/2008); Type: EXPERIMENTAL; Interventions: Drug: Sorafenib Tosylate | Arm Label: Arm II; Type: EXPERIMENTAL; Interventions: Drug: Carboplatin, Drug: Paclitaxel, Drug: Sorafenib Tosylate | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): Arm II | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Arm II | Intervention Type: DRUG; Name: Sorafenib Tosylate; Assigned to Arm(s): Arm I (closed to accrual 10/10/2008), Arm II
C: Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Research Arm; Type: EXPERIMENTAL; Interventions: Drug: Carboplatin, Drug: PLD, Biological: Bevacizumab | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): Research Arm | Intervention Type: DRUG; Name: PLD; Assigned to Arm(s): Research Arm | Intervention Type: BIOLOGICAL; Name: Bevacizumab; Assigned to Arm(s): Research Arm
D: Arm Label: PLD; Type: ACTIVE_COMPARATOR; Interventions: Drug: PLD 40mg/m2 ivgtt q4w | Arm Label: PLD + Apatinib; Type: EXPERIMENTAL; Interventions: Drug: PLD 40mg/m2 ivgtt q4w +Apatinib 250mg po qd | Intervention Type: DRUG; Name: PLD 40mg/m2 ivgtt q4w +Apatinib 250mg po qd; Assigned to Arm(s): PLD + Apatinib | Intervention Type: DRUG; Name: PLD 40mg/m2 ivgtt q4w; Assigned to Arm(s): PLD

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: In dentistry, 3D printing technology is gaining interest. One of the potential application is to construct appliances on 3D reconstructed study models.

The purpose of this study is to compare vacuum formed thermoplastic orthodontic retainers (VFR) constructed on conventional orthodontic study models and reconstructed 3D study models by assessing the oral health-related quality of life (OHRQoL) instrument, Little's Irregularity Index (LII) and compliance.


Options:
A: Arm Label: Thermoplastic Retainer; Type: EXPERIMENTAL; Interventions: Other: orthodontic appliance | Arm Label: Hawley Retainer; Type: ACTIVE_COMPARATOR; Interventions: Other: orthodontic appliance | Intervention Type: OTHER; Name: orthodontic appliance; Assigned to Arm(s): Hawley Retainer, Thermoplastic Retainer
B: Arm Label: Receive electronic reminder; Type: EXPERIMENTAL; Interventions: Other: Electronic reminder | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Electronic reminder; Assigned to Arm(s): Receive electronic reminder
C: Arm Label: CAD/CAM; Type: EXPERIMENTAL; Interventions: Other: Bonding of either CAD/CAM or conventional multistranded stainless steel fixed retainer | Arm Label: Conventional multistranded; Type: ACTIVE_COMPARATOR; Interventions: Other: Bonding of either CAD/CAM or conventional multistranded stainless steel fixed retainer | Intervention Type: OTHER; Name: Bonding of either CAD/CAM or conventional multistranded stainless steel fixed retainer; Assigned to Arm(s): CAD/CAM, Conventional multistranded
D: Arm Label: Conventional; Type: EXPERIMENTAL; Interventions: Device: Vacuum Formed Thermoplastic Retainers Constructed On 3D Reconstructed Orthodontic Study Model | Arm Label: 3D; Type: EXPERIMENTAL; Interventions: Device: Vacuum Formed Thermoplastic Retainers Constructed On 3D Reconstructed Orthodontic Study Model | Intervention Type: DEVICE; Name: Vacuum Formed Thermoplastic Retainers Constructed On 3D Reconstructed Orthodontic Study Model; Assigned to Arm(s): 3D, Conventional

Answer: D